1097-0223/asset/olbannerleft.jpg?v=1&s=ff4f485a6336894d967f5825b88b20a0beae9a93)
1097-0223/asset/olbannerright.jpg?v=1&s=1c95006a5a9f24355db1dab3cc939f86938593db)
Original Paper
Combined QF-PCR and MLPA molecular analysis of miscarriage products: an efficient and robust alternative to karyotype analysis
Article first published online: 18 DEC 2009
DOI: 10.1002/pd.2424
Copyright © 2009 John Wiley & Sons, Ltd.
Additional Information
How to Cite
Donaghue, C., Mann, K., Docherty, Z., Mazzaschi, R., Fear, C. and Ogilvie, C. (2010), Combined QF-PCR and MLPA molecular analysis of miscarriage products: an efficient and robust alternative to karyotype analysis. Prenat. Diagn., 30: 133–137. doi: 10.1002/pd.2424
Publication History
- Issue published online: 25 JAN 2010
- Article first published online: 18 DEC 2009
- Manuscript Accepted: 9 NOV 2009
- Manuscript Revised: 29 OCT 2009
- Manuscript Received: 14 JUL 2009
- Abstract
- References
- Cited By
Keywords:
- QF-PCR;
- MLPA;
- products of conception;
- tissue karyotyping;
- tissue culture;
- miscarriage
Abstract
Objectives
To replace G-banded chromosome analysis for miscarriage products with a combined molecular approach: QF-PCR and MLPA, to increase efficiency, reduce costs, and improve the diagnostic success rate for these samples.
Methods
A review of 10 years of karyotype results for miscarriages products indicated that 2.7% of nonmosaic chromosome imbalance would not be detected by the molecular approach. The molecular approach was validated on 117 samples in parallel with karyotype analysis; no discrepancies were detected. The molecular approach was implemented in September 2007, and in the first 18 months 500 samples were processed.
Results
In 500 samples, 117 samples (23%) were abnormal. Of these abnormalities, 64% were trisomies, 12% triploid, 11% monosomy X and 13% other abnormalities. When compared to karyotype analysis, the success rate was higher (95% cf 70%) and the reporting time was lower (88% within 28 days cf 79%). In addition, efficiency was higher as labour-intensive cell culture and karyotyping were replaced by batch testing and automated analysis.
Conclusions
This molecular approach is less labour-intensive, allows a higher sample throughput and has a higher success rate than karyotype analysis; it is therefore an efficient and cost-effective diagnostic testing strategy for miscarriage products. Copyright © 2009 John Wiley & Sons, Ltd.